Tower Research Capital (TRC)’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$185K Buy
6,974
+5,263
+308% +$139K 0.01% 1850
2025
Q1
$41.3K Sell
1,711
-12,212
-88% -$295K ﹤0.01% 2355
2024
Q4
$560K Buy
13,923
+4,433
+47% +$178K 0.01% 984
2024
Q3
$601K Sell
9,490
-11,022
-54% -$698K 0.02% 756
2024
Q2
$1.09M Buy
20,512
+19,156
+1,413% +$1.02M 0.02% 716
2024
Q1
$111K Sell
1,356
-17,535
-93% -$1.44M ﹤0.01% 1772
2023
Q4
$352K Buy
18,891
+10,820
+134% +$201K ﹤0.01% 1660
2023
Q3
$89.3K Buy
8,071
+5,248
+186% +$58.1K ﹤0.01% 2063
2023
Q2
$45.8K Sell
2,823
-10,150
-78% -$165K ﹤0.01% 2636
2023
Q1
$216K Buy
12,973
+9,391
+262% +$156K 0.01% 1331
2022
Q4
$34K Buy
3,582
+2,934
+453% +$27.8K ﹤0.01% 2646
2022
Q3
$2K Buy
648
+644
+16,100% +$1.99K ﹤0.01% 5621
2022
Q2
$0 Sell
4
-27,749
-100% ﹤0.01% 6550
2022
Q1
$83K Sell
27,753
-32,001
-54% -$95.7K ﹤0.01% 2356
2021
Q4
$275K Buy
59,754
+44,926
+303% +$207K ﹤0.01% 1533
2021
Q3
$94K Buy
14,828
+10,150
+217% +$64.3K ﹤0.01% 2459
2021
Q2
$28K Sell
4,678
-2,148
-31% -$12.9K ﹤0.01% 3576
2021
Q1
$43K Sell
6,826
-4,106
-38% -$25.9K ﹤0.01% 3258
2020
Q4
$61K Buy
10,932
+684
+7% +$3.82K ﹤0.01% 2905
2020
Q3
$60K Sell
10,248
-10,220
-50% -$59.8K ﹤0.01% 3463
2020
Q2
$148K Buy
20,468
+20,368
+20,368% +$147K 0.01% 2091
2020
Q1
$0 Sell
100
-3,111
-97% ﹤0.01% 3956
2019
Q4
$26K Sell
3,211
-4,790
-60% -$38.8K ﹤0.01% 1766
2019
Q3
$55K Buy
8,001
+7,763
+3,262% +$53.4K ﹤0.01% 1731
2019
Q2
$2K Buy
+238
New +$2K ﹤0.01% 3324
2019
Q1
Sell
-8
Closed 4312
2018
Q4
$0 Buy
+8
New ﹤0.01% 4401
2016
Q4
Sell
-528
Closed -$1K 4454
2016
Q3
$1K Sell
528
-200
-27% -$379 ﹤0.01% 3381
2016
Q2
$1K Sell
728
-249
-25% -$342 ﹤0.01% 4227
2016
Q1
$1K Buy
+977
New +$1K ﹤0.01% 3802
2015
Q4
Sell
-1,903
Closed -$11K 5102
2015
Q3
$11K Buy
1,903
+1,597
+522% +$9.23K ﹤0.01% 2247
2015
Q2
$2K Buy
+306
New +$2K ﹤0.01% 3803